Details

Canada’s experience with the live-attenuated influenza vaccine: National Advisory Committee on Immunization responses to post-market vaccine monitoring signals, CCDR 47(5/6) - Canada.ca

Metadata and links for an archived snapshot.

Source: Public Health Agency of Canada
Date: Mar 6, 2026 · edition #7
Timestamp: 2026-03-06T03:47:56.494Z
Language: en
Original URL: https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-5-6-may-june-2021/national-advisory-committee-immunization-recommendations-post-market-vaccine-live-attenuated-influenza-vaccine.html
Replay URL: https://replay.healtharchive.ca/job-7/20260306034756/https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-5-6-may-june-2021/national-advisory-committee-immunization-recommendations-post-market-vaccine-live-attenuated-influenza-vaccine.html#ha_snapshot=892829
ID: 892829
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots